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DYRKs are kinases that self-activate in vitro by auto-
phosphorylation of a YTY motif in the kinase domain,
but their regulation in vivo is not well understood. In
C. elegans zygotes, MBK-2/DYRK phosphorylates
oocyte proteins at the end of the meiotic divisions
to promote the oocyte-to-embryo transition. Here
we demonstrate that MBK-2 is under both positive
and negative regulation during the transition. MBK-2
is activated during oocyte maturation by CDK-1-
dependent phosphorylation of serine 68, a residue
outside of the kinase domain required for full activity
in vivo. The pseudotyrosine phosphatases EGG-4
and EGG-5 sequester activated MBK-2 until the
meiotic divisions by binding to the YTY motif and
inhibiting MBK-20s kinase activity directly, using a
mixed-inhibition mechanism that does not involve
tyrosine dephosphorylation. Our findings link cell-
cycle progression to MBK-2/DYRK activation and
the oocyte-to-embryo transition.
INTRODUCTION
Dual-specificity tyrosine-regulated kinases (DYRKs) are a con-
served family of eukaryotic kinases that belong with cyclin-
dependent kinases (CDKs) and mitogen-activated kinases
(MAPKs) to the CMGC kinase superfamily (Becker and Joost,
1999). DYRK activity depends on a YTY motif located in the
kinase domain in a position similar to the TXY activation loop
motif of MAPKs. Unlike MAPKs, DYRKs catalyze their own tyro-
sine phosphorylation in an intramolecular reaction (Kentrup
et al., 1996; Lochhead et al., 2005). Tyrosine autophosphoryla-
tion is a one-off reaction catalyzed by a DYRK intermediate
present only during translation (Lochhead et al., 2005). Mature
DYRKs are not capable of tyrosine phosphorylation but can
phosphorylate substrates on serines and threonines. Because
of their ability to autophosphorylate in vitro, DYRKs are consid-
ered self-activating kinases, and it is not well understood how
DYRKs are regulated in vivo (Yoshida, 2008).560 Cell 139, 560–572, October 30, 2009 ª2009 Elsevier Inc.DYRKs have been identified in both single-celled andmulticel-
lular eukaryotes; C. elegans MBK-2 belongs to the DYRK2
subclass (Yoshida, 2008). Studies in cell culture usingDrosophila
and mammalian DYRK2s have identified several potential
substrates, including chromatin-remodeling factors, the tran-
scription factors p53, NFAT, and GLI2 (Yoshida, 2008), and kata-
nin p60 (Maddika and Chen, 2009), a substrate also shared by
MBK-2 in C. elegans (see below). Although DYRKs have evolved
to recognize a variety of substrates in different cell types,
a common function linking all DYRKs may be the coordinate
regulation of cell cycle, cell growth, and cell differentiation
(Yoshida, 2008).
MBK-2 functions in the oocyte-to-zygote transition (Pellettieri
et al., 2003). This transition transforms the specialized oocyte
into a totipotent zygote in two stages: oocyte maturation and
egg activation. Oocyte maturation stimulates the first meiotic
division (meiosis I) and ovulation into the spermatheca. Egg acti-
vation is triggered by fertilization, which stimulates meiosis II,
meiotic exit, and the switch to mitosis (McNally and McNally,
2005; Horner and Wolfner, 2008). MBK-20s role in the oocyte-
to-zygote transition is to modify oocyte proteins whose activity
and/or stability need to change after meiosis. Five MBK-2
substrates have been identified so far: MEI-1, OMA-1, OMA-2,
MEX-5, and MEX-6 (Guven-Ozkan et al., 2008; Nishi and Lin,
2005; Nishi et al., 2008; Shirayama et al., 2006; Stitzel et al.,
2006). MEI-1 is the homolog of katanin p60, a microtubule-
severing protein essential for meiosis but toxic during mitosis
(Bowerman and Kurz, 2006). Phosphorylation by MBK-2 triggers
MEI-1 degradation at meiotic exit, allowing formation of the first
mitotic spindle without interference from MEI-1 (Lu and Mains,
2007; Stitzel et al., 2006). OMA-1, and its redundant partner
OMA-2, are required for maturation of the oocyte and for
transcriptional silencing in the zygote (Detwiler et al., 2001;
Guven-Ozkan et al., 2008). This second function depends on
phosphorylation by MBK-2, which increases OMA-10s and
OMA-20s affinity for the transcription factor TAF-4, causing it to
be retained in the cytoplasm (Guven-Ozkan et al., 2008). Phos-
phorylation by MBK-2 also primes OMA-1 and OMA-2 for a
second phosphorylation event that targets OMA-1 and OMA-2
for degradation during mitosis (Nishi and Lin, 2005; Shirayama
et al., 2006). MEX-5 and MEX-6 are two redundant maternal
proteins essential for polarization of the zygote (Schubert
et al., 2000). Phosphorylation by MBK-2 primes MEX-5 and
MEX-6 for subsequent phosphorylation by the polo kinases
PLK-1 and PLK-2, which activate the MEX-5/MEX-6 polarity
function in zygotes (Nishi et al., 2008). In the absence of MBK-2,
oocyte maturation and fertilization occur normally, but the
zygote does not polarize (MEX-5 and MEX-6 are not active),
does not turn off transcription (OMA-1 and OMA-2 cannot
sequester TAF-4), and does not form a normal mitotic spindle
(MEI-1 is not degraded) (Pellettieri et al., 2003; Quintin et al.,
2003; Pang et al., 2004; Guven-Ozkan et al., 2008; Lu andMains,
2007). As a result, 100% of embryos derived from mothers
homozygous for a deletion in mbk-2 [mbk-2(pk1427)] do not
survive embryogenesis (fully penetrant maternal-effect lethality).
Antibodies specific for phosphorylated OMA-1 and MEI-1
have shown that MBK-2 phosphorylates these proteins starting
in anaphase of meiosis I, with increasing levels through meiosis
II and peak levels atmeiotic exit (Nishi and Lin, 2005; Stitzel et al.,
2006). This timing correlates with the progressive relocalization
of MBK-2 from the cortex to the cytoplasm starting in anaphase
of meiosis I and continuing through meiosis II (Stitzel et al., 2007,
2006). Before the meiotic divisions, MBK-2 is maintained at the
cortex by the cortical anchor EGG-3 (Maruyama et al., 2007;
Stitzel et al., 2007). Starting in anaphase of meiosis I, EGG-3
moves into the cytoplasm on vesicles and is slowly turned
over, releasing MBK-2 (Stitzel et al., 2007). This process
depends on CDK-1, the MPF kinase required in maturing
oocytes for entry into meiotic M phase, and on APC/C, the
anaphase-promoting complex required for the transition from
metaphase to anaphase in meiosis I. Loss of CDK-1 or APC
maintains EGG-3 and MBK-2 at the cortex and blocks MEI-1
and OMA-1 degradation. Conversely, inactivation of the CDK-1
inhibitor WEE-1 causes premature cytoplasmic relocalization
of EGG-3 and MBK-2 and premature degradation of MEI-1 in
immature oocytes (Stitzel et al., 2007, 2006). These results
have suggested that the advancing meiotic cell cycle controls
MBK-2 by regulating its access to cytoplasmic substrates via
the cortical anchor EGG-3 (Stitzel et al., 2007).
Analysis of the EGG-3 loss-of-function phenotype, however,
has shown that EGG-3 cannot be the only regulator of MBK-2.
In the absence of EGG-3, MBK-2 is in the cytoplasm with MEI-1
(and OMA-1/2 and MEX-5/6) throughout oocyte growth and
maturation but phosphorylates MEI-1 only after ovulation during
meiosis I (MI) (Stitzel et al., 2007). Therefore, other factors must
inhibit MBK-2 activity before MI. In this study, we identify three
additional MBK-2 regulators: CDK-1, which activates MBK-2
during oocyte maturation, and the pseudophosphatases EGG-4
and EGG-5, which inhibit MBK-2 until the meiotic divisions.
Our findings demonstrate that, although self-activating in vitro,
in vivoDYRKsaresubject tobothpositiveandnegative regulation.
RESULTS
CDK-1 Is Required for MBK-2 Activity In Vivo
Hermaphrodites lacking cdk-1 or the APC subunit mat-1 keep
MBK-2 at the cortex and delay MEI-1 degradation. Loss of the
cortical anchor EGG-3 in mat-1 mutants releases MBK-2 in the
cytoplasm and restores rapid MEI-1 degradation, indicating
that APC’s primary role in this process is to antagonize EGG-3,likely by stimulating its degradation (Stitzel et al., 2007). To deter-
mine whether the requirement for CDK-1 also depends on
EGG-3, we compared GFP:MEI-1 degradation in cdk-1(RNAi)
and cdk-1(RNAi);egg-3(tm1191) hermaphrodites. GFP:MEI-1
degradation was delayed to a similar extent in both genetic
backgrounds (Figure 1A). We conclude that the requirement for
CDK-1 does not depend on EGG-3, suggesting that CDK-1,
unlike APC, promotes MBK-2 activity directly (Figure 1B).
Human Cdk-1 Phosphorylates MBK-2 on S68 In Vitro
To determine whether CDK-1 phosphorylates MBK-2, we per-
formed a kinase assay using a commercial preparation of human
Cdk-1 and a MBP (maltose-binding protein)-MBK-2 fusion
synthesized in E. coli. To prevent autophosphorylation, we
used a MBK-2 mutant lacking a critical residue in the ATP-
binding domain [MBK-2(K196R); Stitzel et al., 2006]. hCdk-1
could phosphorylate MBP:MBK-2(K196R) but not MBP:MEI-1
(Figure 2A). Cyclin-dependent kinases are proline-directed
serine/threonine kinases (see Discussion). TheMBK-2 sequence
contains two S/TP sites (S68 and T470) (Figure S1 available
online). Alanine substitution of S68, but not of T470, eliminated
phosphorylation by Cdk-1 (Figure 2A and data not shown). We
conclude that MBK-2 is a substrate for hCdk-1 in vitro and that
S68 is the primary site of phosphorylation by hCdk-1.
MBK-2 Is Phosphorylated in a CDK-1-Dependent
Manner In Vivo
To determine whether MBK-2 is phosphorylated in vivo, we
examined the mobility of FLAG-tagged MBK-2 expressed in
oocytes and embryos (Experimental Procedures). FLAG:MBK-2
migrated as a doublet (Figure 2B, lane 1). A truncated version of
MBK-2 containing serine 68, but lacking the kinase domain
[GFP:MBK-2(1–109)], also exhibited a retarded isoform (Fig-
ure S2). The slower-migrating band accounted for most of the
protein (73.6%), was sensitive to CIP treatment, and was not
detected in FLAG:MBK-2(S68A), consistent with a phosphory-
lated isoform (Figure 2B). Partial depletion of cdk-1 by RNAi
significantly reduced the levels of the MBK-2 phosphoisoform
(Figure 2B, lane 4). Depletion of another cell-cycle kinase, PLK-1,
had no effect (Figure 2B, lane 5). CDK-1 becomes activated at
the onset of the oocyte-to-embryo transition (Burrows et al.,
2006). Consistent with this, phosphorylated MBK-2 was present
in extracts from gravid adult hermaphrodites, which contain both
oocytes and embryos, but was not detected in extracts from late
L4/young adult hermaphrodites, which contain only oocytes and
very few embryos (Figure 2B). We conclude that MBK-2 is phos-
phorylated in vivo, possibly by CDK-1 or by another kinase
dependent on CDK-1 for activity.
S68 Is Required for MBK-2 Activity In Vivo
To examine the function of S68 in vivo, we compared the abilities
of GFP:MBK-2, GFP:MBK-2(S68A), and GFP:MBK-2(S68E)
(a predicted phosphomimic) to rescue the mbk-2 null mutant
pk1427. Although all three GFP fusions were expressed and
localized similarly (Figure S3), only wild-type GFP:MBK-2 and
GFP:MBK-2(S68E) rescued the embryonic lethality of pk1427
(Figure 2C). To investigate whether the three fusions differ in their
ability to phosphorylate MEI-1, we probed extracts from eachCell 139, 560–572, October 30, 2009 ª2009 Elsevier Inc. 561
strain with an antibody specific for phosphorylated MEI-1
(P-MEI-1) (Stitzel et al., 2006) .mel-26(RNAi)wasused to stabilize
P-MEI-1 (Stitzel et al., 2006). We detected high levels of P-MEI-1
in extracts from hermaphrodites expressing GFP:MBK-2(S68E)
and GFP:MBK-2 transgenes, low (but above background) levels
in extracts from hermaphrodites expressing GFP:MBK-2(S68A),
and no P-MEI-1 hermaphrodites expressing no transgene
(Figure 2C). We conclude that phosphorylation of S68 stimulates
MBK-20s ability to phosphorylate MEI-1 in vivo.
If CDK-1 activates MBK-2 via phosphorylation at S68, loss of
CDK-1 should reduce MEI-1 phosphorylation levels in the pres-
ence of wild-type MBK-2 but not in the presence of MBK-2
mutated at S68. As predicted, we found that depletion of
CDK-1 by RNAi reduced P-MEI-1 in extracts from hermaphro-
dites expressing GFP:MBK-2, but not in extracts from hermaph-
rodites expressing GFP:MBK-2(S68A) or GFP:MBK-2(S68E)
(Figure 2C). This result was confirmed by immunofluorescence
staining of embryos (Figure 2D). The finding that MBK-2(S68E)
bypasses the requirement for cdk-1 is strong genetic evidence
for S68 being a site for CDK-1-dependent phosphorylation. We
conclude that CDK-1-dependent phosphorylation of S68 stimu-
lates MBK-20s ability to phosphorylate MEI-1.
S68 Modulates MBK-2 Kinase Activity in Worms but Not
in Mammalian Cells
S68 phosphorylation could stimulate MBK-20s intrinsic kinase
activity or MBK-20s access to MEI-1. To distinguish between
Figure 1. CDK-1 Is Required for MEI-1 Degrada-
tion and This Requirement Cannot Be Suppressed
by Loss of EGG-3
(A) Embryos in uteri of hermaphrodites of indicated geno-
types were scored for GFP:MEI-1 and for position with
respect to the spermatheca (from youngest [position 1]
to oldest [position 6]). Inmat-1(RNAi), GFP:MEI-1 is main-
tained in all embryos, but degradation is restored if egg-3
is also absent. In cdk-1(RNAi), GFP:MEI-1 is maintained
past the third position embryo, and this ‘‘delayed degrada-
tion’’ pattern is not changed significantly in the absence of
egg-3. Unlike mat-1(RNAi), which efficiently maintains
MBK-2 at the cortex, cdk-1(RNAi) leads to a more pleio-
tropic arrest with embryos eventually releasing MBK-2
into the cytoplasm, which may explain why GFP:MEI-1 is
eventually degraded in cdk-1(RNAi).
(B) A genetic model describing the epistasis results
obtained in (A). cdk-1 is required to initiatemeioticMphase
(Burrows et al., 2006) and therefore is considered formally
here as an ‘‘activator’’ of the APC subunit mat-1.
these possibilities, we compared the in vitro
kinase activities of GFP:MBK-2, GFP:MBK-2
(S68A), and GFP:MBK-2(S68E) immunoprecipi-
tated from worm extracts. We found that the
fusions showed three different activity levels:
low (S68A), intermediate (WT), and high (S68E)
(Figure 3A). We conclude that S68 modulates
MBK-20s intrinsic kinase activity.
To determine whether S68 affects MBK-2
kinase activity directly, we asked whether
MBK-2 expressed in mammalian cells also requires S68 and/or
phosphorylation for full activity. FLAG:MBK-2 immunoprecipi-
tated from HEK293 cell extracts migrates as a single isoform
(Figure 3B). Addition of ATP and hCdk-1 to the immunoprecipi-
tates caused the appearance of a slower isoform, similar to
what is seen for FLAG:MBK-2 in worms (Compare Figure 3B to
Figure 2B). Appearance of the slower isoform requires S68 and
P69 but does not require MBK-20s own kinase activity. Remark-
ably, we detected no difference in kinase activity among wild-
type MBK-2 and the S68 and P69 mutants treated or not treated
with hCdk-1 (Figures 3A and 3B). We repeated these experi-
ments with MBK-2 made as an MBP fusion in E. coli and again
saw no difference between wild-type and the S68 mutants
(Figure S4). We conclude that phosphorylation of S68 does not
affect kinase activity directly but may affect it indirectly by
opposing negative regulators or modifications associated with
MBK-2 in worms (see Discussion). Consistent with this hypoth-
esis, FLAG:MBK-2 immunoprecipitated from mammalian cells
was 2.53 more active than GFP:MBK-2 immunoprecipitated
from worms (Figure 3A).
EGG-4/5 Negatively Regulates MBK-2 Activity
in Maturing Oocytes
Phosphorylation of the CDK-1 target histone H3 has been
detected in the last 2–3 oocytes, with highest levels in the oocyte
nearest the spermatheca (‘‘proximal’’ oocytes that have initiated
maturation and are transitioning to meiotic M phase) (Burrows562 Cell 139, 560–572, October 30, 2009 ª2009 Elsevier Inc.
Figure 2. MBK-2 Is Activated by CDK-1
(A) hCdk-1 phosphorylates MBK-2. hCdk-1 (New England Biolabs) was incubated with the indicated maltose-binding fusions (partially purified from E. coli) in the
presence of g-32P-ATP. Coomassie staining controls for loading of MBP fusions. We estimate that 43% of MBP:MBK-2 was phosphorylated in this assay.
MBK-2(K196R) is a mutation in the ATP-binding domain of MBK-2 (Figure S1) that eliminates MBK-20s own kinase activity (Stitzel et al., 2006).
(B) FLAG-tagged MBK-2 was immunoprecipitated from adults (hermaphrodites with four or more embryos) or L4 (late L4/early adults with 0–1 embryo in uterus)
whole worm extracts, treated with Calf Intestinal Alkaline Phosphatase (CIP), and western blotted with anti-FLAG antibody. Numbers represent the percent of
phosphorylated FLAG:MBK-2 compared to total FLAG:MBK-2.
(C) mbk-2(pk1427) hermaphrodites transformed with the indicated transgenes were (1) tested for rescue of maternal-effect lethality (% viable embryos, n =
number of embryos scored) and (2) western blotted for phospho-MEI-1. Numbers underneath the phospho-MEI-1 bands indicate relative intensity with respect
to that observed in mbk-2(pk1427) hermaphrodites expressing wild-type MBK-2 (set to 100%). mel-26(RNAi) is used to stabilize phospho-MEI-1. Note that
cdk-1(RNAi) reduces the level of phospho-MEI-1 significantly only in hermaphrodites carrying the wild-type transgene (100 versus 42).
(D) Immunofluorescence using the anti-phospho-MEI-1 antibody on embryos derived from hermaphrodites of indicated genotype. Note that cdk-1(RNAi) elim-
inates staining in embryos from mothers expressing the wild-type MBK-2 transgene, but not from mothers expressing the MBK-2(S68E) transgene.et al., 2006). If CDK-1 phosphorylates and activates MBK-2 with
similar timing, P-MEI-1 should be present in proximal oocytes.
Instead, we detect P-MEI-1 only after ovulation, in zygotes in
anaphase of meiosis I (Stitzel et al., 2006).We showed previously
that this timing depends in part on the cortical anchor EGG-3,
which tethers MBK-2 at the cortex until anaphase I (Stitzelet al., 2007). In egg-3 mutants, P-MEI-1 appears precociously
during metaphase I but remains off in oocytes, suggesting the
existence of other negative regulators (Stitzel et al., 2007).
EGG-4 (T21E3.1) and EGG-5 (R12E2.10) are two oocyte proteins
that like EGG-3 are required for egg activation and MBK-2 local-
ization to the cortex (Parry et al., 2009). Single deletions in egg-4Cell 139, 560–572, October 30, 2009 ª2009 Elsevier Inc. 563
or egg-5 cause low-penetrance egg lethality, but codepletion of
egg-4 and egg-5 using RNAi causes 100% lethality and causes
GFP:MBK-2 to become cytoplasmic in oocytes as is observed in
egg-3(RNAi) (Parry et al., 2009). Consistent with their functionally
redundant roles, egg-4 and egg-5 encode two 753 amino acid
proteins that differ only by 6 amino acids (99.2% identical,
Figure S5). Like EGG-3 (Maruyama et al., 2007), EGG-4 and
EGG-5 contain a predicted protein tyrosine phosphatase (PTP)
domain with substitutions in active site residues (Figure S5).
‘‘PTP-like’’ proteins are predicted to lack phosphatase activity
but may retain the ability to bind phosphorylated tyrosines
(Hunter, 1998; Wishart and Dixon, 1998).
To investigate whether EGG-4/5 regulate MBK-2 activity, we
examined the distribution of P-MEI-1 in hermaphrodites
depleted for EGG-4/5 by RNAi. mel-26(RNAi) was used to
stabilize P-MEI-1 (Stitzel et al., 2006). As seen in egg-3mutants,
P-MEI-1 was present in all egg-4(RNAi);egg-5(RNAi) zygotes
including those in metaphase of meiosis I (Figure S6). In
addition, in 13.8% of egg-4(RNAi);egg-5(RNAi) gonads (Table
S1), we detected P-MEI-1 in the two most proximal oocytes
(Figure 4A). This pattern and the low frequency suggest that
MBK-2 activity in egg-4/5(RNAi) depends on oocyte maturation
and activation of MBK-2 by CDK-1. If so, P-MEI-1-positive
gonads should increase in egg-4/5(RNAi) hermaphrodites
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Figure 3. S68 Is Required for Full Kinase Activity of
MBK-2 Synthesized in Oocytes but Not of MBK-2
Synthesized in Mammalian Cells
(A) MBK-2 fusions immunoprecipitated from whole worm
extracts (w), or from mammalian cells (m), were treated
or not treated with hCdk-1 and incubated with recombi-
nant MEI-1(aa 51–150) and g-32P-ATP in kinase buffer
for the time shown. Relative kinase activity was calculated
by measuring 32P incorporation in MEI-1 expressed as a
ratio over the signal obtained for wild-type worm MBK-2
at 60 min. Error bars represent standard deviation from
three independent immunoprecipitation experiments.
(B) FLAG:MBK-2 fusions immunoprecipitated from
mammalian cells were incubated with cold ATP and with
or without hCdk-1. Half of the samples were run on SDS-
PAGE (note the presence of slower isoforms in lanes 1,
5, and 6) and the other half was used in a kinase assay
again recombinant MEI-1(aa 51–150) (no change in kinase
activity was detected except in K196R, which is not active,
as expected; Stitzel et al., 2007). Numbers (%) represent
the relative amount of phosphorylated FLAG:MBK-2 with
respect to total FLAG:MBK-2.
expressing GFP:MBK-2(S68E). As predicted,
we found that 100% of egg-4/5(RNAi);GFP:
MBK-2(S68E) gonads were positive for P-MEI-1
(Table S1). Furthermore, in 75% of these
gonads, the pattern of P-MEI-1 was expanded
to three or more oocytes (Figure 4A). We also
observed a (more modest) increase in P-MEI-1
in egg-4/5(RNAi) hermaphrodites expressing
wild-type GFP:MBK-2 in addition to endoge-
nous MBK-2 (Figure 4A and Table S1).
Appearance of P-MEI-1 in oocytes was strictly
dependent on egg-4/5(RNAi) and on S68. No
P-MEI-1 was observed in wild-type, egg-3(tm1191), or egg-3
(RNAi) hermaphrodites expressing GFP:MBK-2 or GFP:MBK-2
(S68E) or in mbk-2(pk1427);egg-4/5(RNAi) hermaphrodites
expressing GFP:MBK-2(S68A) (Figure 4A and Table S1). We
conclude that EGG-4/5 are required to inhibit CDK-1-activated
MBK-2 during oocyte maturation.
EGG-4/5 Are Enriched on the Cortex of Oocytes
To determine the distribution of EGG-4 and EGG-5, we gener-
ated a polyclonal antibody against EGG-4 and EGG-5 (Experi-
mental Procedures). We confirmed that the antibody recognizes
both proteins by western blotting of E. coli-expressed EGG-4
and EGG-5 (data not shown). Like EGG-3 and MBK-2, EGG-4/5
localize to the cortex of oocytes (Figure 4B). In addition, EGG-4/5
were also detected in oocyte nuclei. The cortical and nuclear
signals were eliminated by RNAi codepletion of EGG-4 and
EGG-5, confirming that they correspond to endogenous EGG-
4/5. Staining of hermaphrodites homozygous for single deletions
in either EGG-4 or EGG-5 gave the same pattern as wild-type,
confirming that EGG-4 and EGG-5 are both expressed in
oocytes (data not shown). In zygotes in meiosis II, EGG-4/5
were enriched on subcortical puncta, also positive for EGG-3
(Figure 4C). EGG-3-positive puncta invade the cytoplasm during
meiosis II (Stitzel et al., 2007). EGG-4/5 puncta, in contrast, were564 Cell 139, 560–572, October 30, 2009 ª2009 Elsevier Inc.
prominent only near the cortex and around the spermpronucleus
(Figure S6). No EGG-4/5 were detected above background in 2-
cell embryos (Figure 4C).
GFP:MBK-2(WT) GFP:MBK-2(S68E)
mel-26(RNAi)
mel-26;egg-3(RNAi)
mel-26;egg-4/5(RNAi)
transgene: _
A
anti-MBK-2 anti-EGG-3 anti-EGG-4/5
mbk-2(RNAi)
egg-3(RNAi)
egg-4/5(RNAi)
N2
B
C anti-EGG-3 anti-EGG-4/5
metaphase I
meiosis II
2-cell
Figure 4. EGG-4 and EGG-5 Inhibit MBK-2 in Oocytes and Localize
to the Oocyte Cortex
(A) Gonads from hermaphrodites with indicated genotypes were fixed and
stained with anti-P-MEI-1 antibody.mel-26(RNAi) is used to stabilize P-MEI-1.
Note that (1) P-MEI-1 is only seen when EGG-4 and EGG-5 are inactivated by
RNAi and (2) the pattern of P-MEI-1 correlates with oocyte maturation in
gonads expressing wild-type MBK-2 and is expanded in gonads expressing
MBK-2(S68E). See Table S1 for numbers and additional genotypes examined.
(B) Gonads were stained with anti-MBK-2, anti-EGG-3, and anti-EGG-4/5 anti-
bodies. Note that EGG-4/5 are detected on both the cortex and the nuclei of
oocytes. The patterns seen after the indicated RNAi treatments suggest that
the cortical localization of (1) EGG-3 does not require EGG-4/5 or MBK-2, (2)
EGG-4/5 requires EGG-3, but not MBK-2, and (2) MBK-2 requires EGG-3
and EGG-4/5.
(C) Embryos costained with anti-EGG-3 and anti-EGG-4/5 antibodies. EGG-3
and EGG-4/5 relocalize from the cortex to subcortical speckles during the
transition from meiosis I to meiosis II. In the 2-cell stage, occasional EGG-3-
positive speckles can still be detected. By this stage, the EGG-4 signal is at
background levels.To examine the relationships among EGG-4/5, EGG-3, and
MBK-2 localizations in vivo, we stained wild-type, egg-3(RNAi),
egg-4/5(RNAi), and mbk-2(RNAi) hermaphrodites with the
EGG-4/5 antibody and antibodies against EGG-3 and MBK-2
(Stitzel et al., 2007). We found that, in oocytes, (1) MBK-2
requires both EGG-3 and EGG-4/5 for cortical localization, (2)
EGG-4/5 require EGG-3, but not MBK-2, and (3) EGG-3 does
not require MBK-2 or EGG-4/5 (Figure 4B). These observations
are consistent with our earlier finding that EGG-3, although
required for MBK-2 cortical localization, is not sufficient on its
own to target MBK-2 to the cortex (Stitzel et al., 2007). In egg-3
mutants, EGG-4/5 and MBK-2 are cytoplasmic (Figure 4B), yet
MBK-2 remains inhibited in oocytes (Figure 4A). This observation
indicates that inhibition of MBK-2 by EGG-4/5 does not require
EGG-3 or cortical localization, raising the possibility that EGG-
4/5 inhibit MBK-2 directly.
MBK-2 Binds Directly to EGG-4/5 and This Interaction
Depends on the MBK-2 Activation Loop
MBK-2 and EGG-3 bind directly in vitro (Stitzel et al., 2007). To
test whether MBK-2 also binds to EGG-4 and EGG-5, we
expressed each separately as GST and FLAG fusion proteins
in E. coli. GST:MBK-2-coupled beads could pull down FLAG:
EGG-4 and FLAG:EGG-5 (and FLAG:EGG-3) from E. coli
extracts (Figure 5A). Mutations in the pseudophosphatase
active sites of EGG-4 and EGG-3 reduced binding (Figures 5A
and S7). Mutation in the ATP-binding site (K196R) similarly
reduced binding to EGG-4/5 but not to EGG-3 (Figure 5A). Muta-
tions in the two tyrosines in the MBK-2 activation loop (Y325F,
Y327F) severely reduced binding to EGG-4 and EGG-5 but
not to EGG-3. Further analyses revealed that unlike EGG-4
and EGG-5, EGG-3 binds to the amino terminus of MBK-2
(Figure S7).
To further investigate the EGG-4/MBK-2 interaction, we
expressed both in HEK293 cells and monitored, in parallel,
binding and MBK-2 tyrosine phosphorylation. We found that
tyrosine phosphorylation requires the ATP-binding site (K196)
and the second tyrosine in the activation loop (Y327) of MBK-2
(Figure 5B), as shown previously for Drosophila DYRK2
(Lochhead et al., 2005). Mutants that lack tyrosine phosphoryla-
tion but retain at least one tyrosine (K196R and Y327F) bound
weakly but still detectably to EGG-4, whereas the double mutant
lacking both tyrosines (Y325F, Y327F) showed no detectable
binding (Figure 5B). The EGG-4 phosphatase domain alone
was sufficient for binding, and mutations in the pseudophospha-
tase active site reduced but did not eliminate binding (Figure 5C).
We conclude that EGG-4 uses its phosphatase domain to
interact with the tyrosines in the activation loop of MBK-2, and
that this interaction is enhanced by, but does not absolutely
require, tyrosine phosphorylation.
MBK-2 Interacts with EGG-4/5 In Vivo and This
Interaction Is Essential for Localization
to the Oocyte Cortex
To determine whether MBK-2 and EGG-4/5 interact in worms,
we immunoprecipitated MBK-2 and probed the immunoprecip-
itate with the EGG-4/5 antibody. We detected EGG-4/5 in
MBK-2 immunoprecipitates but not in the immunoprecipitatesCell 139, 560–572, October 30, 2009 ª2009 Elsevier Inc. 565
Figure 5. EGG-4/5 Interact with MBK-2 In Vivo and In Vitro
(A) EGG-4/5 bind to MBK-2 in vitro. Extracts from E. coli expressing the indicated FLAG:EGG fusions were pulled down with the indicated GST:MBK-2 fusions
and immunoblotted with an anti-FLAG antibody. Numbers (%) indicate signal intensity relative to wild-type. Input is 1/50th of the pull-down.
EGG-4(H599A,G603A, R606A) has mutations in consensus residues in the predicted phosphatase catalytic site (see Figure S5).
(B) EGG-4 interacts with MBK-2 in mammalian cells. HA-tagged EGG-4 and FLAG-tagged MBK-2 were coexpressed in HEK293 cells, immunoprecipitated with
anti-FLAG, and probed with an anti-phosphotyrosine antibody and an anti-HA antibody. Input is 1/100 of the IP.566 Cell 139, 560–572, October 30, 2009 ª2009 Elsevier Inc.
of the control rabbit IgG antibody. MBK-2 immunoprecipitates
did not contain tubulin, confirming the specificity of the assay
(Figure 5D).
To explore the specificity of the MBK-2/EGG-4/5 interaction
further, we used GFP-tagged MBK-2 fusions and an anti-GFP
antibody for immunoprecipitation. Wild-type GFP:MBK-2 immu-
noprecipitated endogenous EGG-4/5 (Figure 5E). As observed in
E. coli and mammalian cells, MBK-2(K196R) bound EGG-4/5
with reduced affinity, and MBK-2(Y325F, Y327F) bound even
more poorly, if at all (Figure 5E). In oocytes, GFP:MBK-2
(K196R) localizes to the cortex as does wild-type MBK-2,
whereas GFP:MBK-2(Y325F, Y327F) remains cytoplasmic
(Figure S3). We conclude that (1) MBK-2 and EGG-4/5 interact
in vivo, (2) the MBK-2/EGG-4/5 interaction requires the activa-
tion loop tyrosines and only partially depends on tyrosine phos-
phorylation (confirming the in vitro findings), and (3) the MBK-2/
EGG-4/5 interaction is essential for localizing MBK-2 to the
cortex.
GFP:MBK-2(K196R) and GFP:MBK-2(Y325F, Y327F) also
bound poorly to EGG-3 in worm extracts (Figure 5E), in contrast
to what we observed with partially purified proteins in vitro
(Figure 5A). This observation suggests that, in oocytes, the
MBK-2/EGG-3 interaction depends on MBK-2 binding to EGG-
4/5. This hypothesis is consistent with the fact that EGG-3 is
not sufficient to localize MBK-2 to the cortex in the absence of
EGG-4/5 (Figure 4B).
EGG-4 Inhibits MBK-2 Activity In Vitro
To test whether EGG-4 or EGG-3 inhibit MBK-2 activity directly,
we performed an in vitro MBK-2 kinase assay in the presence of
EGG-4 or EGG-3, partially purified as FLAG fusions from E. coli.
We found that EGG-4 reduces MBK-20s ability to phosphorylate
the MEI-1 fragment MEI-1(51–150) in a dose-dependent manner
(Figures 6A and S8). The effect was specific to EGG-4, as we
observed no significant inhibition in the presence of EGG-3
(Figures 6A and S8). Mutations in the pseudophosphatase
active site reduced the strength of inhibition (Figures 6A and
S8). We conclude that EGG-4 inhibits MBK-2 activity directly
and that this inhibition requires the phosphatase domain of
EGG-4.
EGG-4 is not predicted to possess tyrosine phosphatase
activity because of its noncanonical phosphatase active site
(Figure S4). To verify that EGG-4 does not dephosphorylate
MBK-2, we incubated MBP:MBK-2 with EGG-4 and monitored
both MBK-2 tyrosine phosphorylation and kinase activity in
parallel. As expected, we observed a reduction in kinase activity
but observed no change in tyrosine phosphorylation (Figure 6B).
We conclude that EGG-4 inhibition of MBK-2 does not involve
dephosphorylation of the activation loop.Next, we compared the kinetics of MBK-2 kinase activity with
and without EGG-4 and in the presence of varying amount of the
substrate MEI-1(51–150). Figure 6C shows that EGG-4 affects
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Figure 6. EGG-4 Inhibits MBK-2 Kinase Activity In Vitro
(A) 0.5-, 1-, and 2-fold molar excess of FLAG-tagged EGG-3, EGG-4, and
EGG-4(H599A,G603A, R606A) were added to MBP:MBK-2 kinase reactions
and the amount of phosphorylated MEI-1 was quantified (as in Figure 3)
after 30 min. Levels are expressed as ratio to that observed with MBP:
MBK-2 alone (first lane). Error bars represent standard deviation from three
experiments.
(B) Same as (A), but kinase reactions were split to examine amount of tyrosine-
phosphorylated MBK-2 (P-Tyr), amount of MBP:MBK-2, and amount of phos-
phorylated MEI-1 (P32). Note that addition of EGG-4 lowers the amount of
phosphorylated MEI-1 but does not affect tyrosine phosphorylation of MBK-2.
(C) Michaelis-Menten plot to compare MBK-2 enzyme kinetics in the presence
(23 molar excess) or absence of FLAG:EGG-4.(C) EGG-4 uses its protein tyrosine phosphatase (PTP) domain to interact with MBK-2. HA- and FLAG-tagged proteins were coexpressed and immunoprecip-
itated as in (B). EGG-4(380–662) is the PTP domain (see Figure S5). Input is 1/100 of the IP.
(D) EGG-4/5 and MBK-2 interact in worm extracts. Anti-MBK-2 immunoprecipitates from whole worm extracts were western blotted with anti-EGG-4/5 antibody
and anti-tubulin antibody (negative control). Input is 1/100th of the IP. Rabbit IgG is a negative control antibody.
(E) The EGG-4/5/MBK-2 interaction requires the MBK-2 activation loop in vivo. Anti-GFP immunoprecipitates from whole worm extracts were western blotted
with anti-EGG-4/5 and anti-EGG-3 antibodies. Anti-GFP pulls down endogenous EGG-4/5 and EGG-3 from worms expressing wild-type GFP:MBK-2 or
GFP:MBK-2(K196R) (kinase dead), but not from worms expressing GFP:MBK-2(Y325F,Y327F) (activation loop mutant). Numbers (%) indicate signal intensity
relative to wild-type. Input is 1/100th of the IP.Cell 139, 560–572, October 30, 2009 ª2009 Elsevier Inc. 567
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Figure 7. Working Model for MBK-2 Regulation during the Oocyte-to-Embryo Transition
Red and green colors indicate the distribution of MBK-2 during the oocyte-to-embryo transition. MBK-2 goes from cortically enriched to cytoplasmic during the
transition (Stitzel et al., 2006) and from inactive (red) to active (green). Under each stage, we indicate (1) the pattern of P-MEI-1 observed in wild-type and in the
indicated genotypes and (2) the proposed primary mode of MBK-2 regulation for that stage.the Km (substrate concentration at which V = Vmax/2) and, to
some extent, also the Vmax (reaction maximal velocity) of the
MBK-2 kinase reaction. These results suggest that EGG-4 may
function as a mixed-type inhibitor, i.e., EGG-4 interferes with
substrate binding (increases the Km) and with turn-over rate
(lowers the Vmax) (Berg et al., 2006).
DISCUSSION
We have investigated the mechanisms that regulate MBK-2
kinase activity during the oocyte-to-zygote transition and have
identified three modes of regulation: activation by CDK-1-
dependent phosphorylation, inhibition by EGG-4/5, and cortical
anchoring (Figure 7). We discuss each of these in turn.
Activation by CDK-1
TheMPF kinase CDK-1 drives oocytematuration and themeiotic
divisions in all animals (Voronina and Wessel, 2003). Our results
suggest that, in parallel to its cell-cycle role, CDK-1 also acti-
vates MBK-2. cdk-1 is required for mbk-2 activity in vivo and
promotes phosphorylation of S68 in vivo and in vitro. MBK-
2(S68A) has low kinase activity; in contrast, MBK-2(S68E) has
high kinase activity and bypasses the requirement for cdk-1.
We conclude that phosphorylation of S68 is required for MBK-
2 activation in vivo and suggest that CDK-1 may be the kinase
responsible.
The preferred consensus for Cdk-1-Cyclin B in mammalian
cells is a target serine or threonine, followed immediately by
a proline, and an arginine or lysine residue in the +3 position
([ST]Px[KR]) (Holmes and Solomon, 1996; Songyang et al.,
1994). S68 is followed by a proline but does not have an arginine
or lysine in the +3 position. A recent study reported that 39% of
direct Cdk-1-Cyclin B targets in HeLa cells also contain only the
minimal [ST]P site (Blethrow et al., 2008). Although our data are
consistent with direct phosphorylation of S68 by CDK-1, we do
not exclude the possibility that a CDK-1-dependent kinase,
rather than CDK-1 itself, is involved.568 Cell 139, 560–572, October 30, 2009 ª2009 Elsevier Inc.What is the mechanism by which phosphorylation of S68 acti-
vates MBK-2? MBK-2 synthesized in mammalian cells or in E.
coli does not require S68 or CDK-1 phosphorylation for full
activity, suggesting that S68 phosphorylation regulates MBK-2
indirectly, by opposing the effects of negative regulators present
in oocytes. One possibility is that upon synthesis in early oogen-
esis, MBK-2 enters an inhibitory complex or acquires an inhibi-
tory modification, the effect of which is reversed during oocyte
maturation by phosphorylation of S68. We have identified
EGG-4 and EGG-5 as inhibitors of MBK-2 during oogenesis
(see below), but EGG-4/5 are unlikely to be the inhibitors
opposed specifically by CDK-1 for the following reasons: (1) in
the absence of EGG-4/5, MBK-2 still requires oocyte maturation
and S68 to become active; (2) EGG-4/5 inhibit MBK-2(S68E) in
oocytes (Table S1); and (3) MBK-2, MBK-2(S68A), and MBK-
2(S68E) all bind EGG-4/5 in vivo with similar affinities (Fig-
ure S3B). Instead, our results suggest that there is another, yet-
to-be-discovered mechanism that functions redundantly with
EGG-4/5 to inhibit MBK-2 before oocyte maturation (Figure 7).
Cell cycle-dependent upregulation of kinase activity has also
been reported for Pom1p, the Schizosaccharomyces pombe
DYRK homolog (Bahler and Nurse, 2001). Pom1p kinase activity
is upregulated 10- or more-fold after S phase, by an unknown
mechanism (Bahler and Nurse, 2001). Pom1p has a long N-
terminal extension, which includes a serine/threonine-rich
domain (Bahler and Pringle, 1998). Deletion of the N-terminal
extension disrupts Pom1p localization in vivo but does not elim-
inate Pom1p kinase activity, consistent with a regulatory role.
Human and Drosophila DYRK2s also contain a serine/threo-
nine-rich region upstream of the kinase domain (Figure S1). We
suggest that the N terminus of DYRKs may generally serve as
a docking site for cellular proteins that sequester and/or inacti-
vate DYRKs. Phosphorylation of the N terminus by serine-threo-
nine kinases that mediate cell cycle or developmental transitions
could weaken these interactions, leading to DYRK activation.
Regulation by sequestration and phosphorylation has also
been proposed for Mirk/Dyrk1B (Lim et al., 2002).
Inhibition by the Pseudophosphatases
EGG-4 and EGG-5
After CDK-1-dependent activation, MBK-2 remains inhibited
by the redundant (99% identical) protein tyrosine phospha-
tase-like (PTPL) proteins EGG-4 and EGG-5. As predicted for
a PTPL (Hunter, 1998; Wishart and Dixon, 1998), EGG-4 is
unable to dephosphorylate MBK-2 but recognizes the phos-
phorylated YTY motif in the MBK-2 activation loop. Surpris-
ingly, EGG-4 and EGG-5 binding to MBK-2 is stimulated by,
but does not absolutely depend on, tyrosine phosphorylation,
suggesting that PTPLs may also recognize unphosphorylated
tyrosines.
PTPLs have been proposed to function as ‘‘antiphospha-
tases’’ protecting phosphotyrosines from dephosphorylation
by ‘‘real’’ PTPs (Hunter, 1998; Wishart and Dixon, 1998). For
example, the Arabidopsis PTPL Pasticcino2 I binds to cyclin-
dependent kinase CDKA;1 phosphorylated on Tyr15. Phosphor-
ylated CDKA is inactive and is activated by dephosphorylation
by the phosphatase CDC25. In pasticcino2 mutants, CDKA;1 is
dephosphorylated (presumably by CDC25) and activated
(Da Costa et al., 2006). It is highly unlikely that EGG-4 and
EGG-5 inhibit MBK-2 by a similar mechanism since tyrosine-
phosphorylated MBK-2 is active and EGG-4 inhibits MBK-2
in vitro in the absence of any other proteins. For this reason,
we prefer to refer to EGG-4 and EGG-5 as pseudophosphatases,
rather than antiphosphatases. We do not exclude the possibility,
however, that in vivo EGG-4/5 also serve to protect MBK-2 from
dephosphorylation. A dual inhibitor/protector role would ensure
that maximal MBK-2 activity is delivered to the zygote cytoplasm
upon release from the cortex.
Our enzymatic analysis suggests that EGG-4 interferes
both with catalysis and substrate binding. Inhibition of kinase
activity by a protein that binds to the activation loop has been
observed previously (Depetris et al., 2005). The SH2 (Src
homology-2) domain protein Grb14 binds to the phosphotyro-
sines in the activation loop of the insulin receptor (IR). Binding
of the SH2 domain positions an adjacent domain (BPS, between
PH and SH2) in the substrate-binding pocket of the IR kinase
domain (Depetris et al., 2005). The BPS inhibits kinase activity
by acting as a pseudosubstrate (Depetris et al., 2005). EGG-4
contacts theMBK-2 activation loop using a conserved phospha-
tase domain; we do not know whether this domain could also
function as a pseudosubstrate. Another possibility is that EGG-
4 binding forces the MBK-2 activation loop, and nearby catalytic
loop, into an unfavorable conformation, perhaps one resembling
the unphosphorylated state.
To our knowledge, EGG-4/5 are the first PTPLs proposed to
function directly as kinase inhibitors. ‘‘Mutant’’ PTP domains,
with substitutions predicted to eliminate phosphatase activity,
have been identified in all organisms examined to date and
in all subclasses of the PTP family (Pils and Schultz, 2004).
In theC. elegans genome, 62% of all PTP domains are predicted
to be inactive (57 of 91), and in the human genome, 40% are pre-
dicted to be inactive (20 of 51) (Pils and Schultz, 2004). The
majority have unknown functions. It will be important to deter-
mine which PTPLs behave primarily as phosphatase antagonists
(‘‘antiphosphatases’’), and which also have autonomous activi-
ties as we demonstrate here for EGG-4 and EGG-5.Cortical Anchoring and Cell-Cycle Regulation
of the Oocyte-to-Embryo Transition
Binding to EGG-4 and EGG-5 not only inhibitsMBK-2 activity but
also sequesters MBK-2 at the cortex away from its cytoplasmic
substrates. This localization depends on EGG-3, another
PTPL that binds to MBK-2 and is required for both MBK-2 and
EGG-4/5 cortical localization (Maruyama et al., 2007; Stitzel
et al., 2007). Although EGG-3 binds to MBK-2 directly in vitro
(Stitzel et al., 2007), in vivo EGG-3 only recruits MBK-2 to the
cortex in the presence of EGG-4 and EGG-5, suggesting
that EGG-3 functions as an adaptor linking the EGG-4/5/
MBK-2 complex to the cortex. During the meiotic divisions,
EGG-3 and EGG-4/5 are internalized on subcortical puncta
and are eventually degraded. EGG-3 degradation depends on
the anaphase-promoting complex and on several destruction
boxes present in EGG-3 (Stitzel et al., 2007). EGG-4/5 also
require APC for cortical release (K.C.-C.C., unpublished data)
and contain four putative destruction boxes (RXXL) (Figure S5).
We suggest that APC-stimulated turnover of EGG-3, EGG-4,
and EGG-5 releases CDK-1-activatedMBK-2 into the cytoplasm
of zygotes in meiosis II. We note that the egg-3 phenotype
(premature phosphorylation of MEI-1 in metaphase of meiosis I
but not earlier) and the observation that egg-3 is epistatic
to the APC subunit mat-1 (Stitzel et al., 2007) suggest that
EGG-3-dependent sequestration becomes the primary mode
of MBK-2 regulation by metaphase of meiosis I (Figure 7). We
do not know why EGG-4/5 are no longer sufficient to inhibit
MBK-2 at that time. Unlike EGG-3 and MBK-2, EGG-4/5 do
not persist on cytoplasmic puncta during internalization in
meiosis II (Figure S6C), raising the possibility that EGG-4/5 are
degraded and/or released from the MBK-2 complex before
EGG-3.
Parallel regulation of MBK-2 by CDK-1 and the APC-regulated
EGG proteins ensures that MBK-2 activation and release are
tightly and irreversibly linked to meiotic progression. Fertilization
is not required forMBK-2 activation (Stitzel et al., 2006). Our find-
ings illustrate how one aspect of the oocyte-to-embryo transition
(themodification and degradation of oocyte proteins) is triggered
cell-autonomously by the advancing meiotic cell cycle. DYRKs
in other organisms have also been implicated in cellular transi-
tions that require coordination between cell cycle and cell differ-
entiation (Friedman, 2007). Our analysis of MBK-2 illustrates how
cell-cycle regulation can be imposed on a DYRK by a combina-
tion of positive and negative inputs.
EXPERIMENTAL PROCEDURES
Nematode Strains
C. elegans strains (Table S2) were derived from the wild-type Bristol strain N2
and reared by standard procedures (Brenner, 1974).
Transgene Construction and Transformation
All transgenes were driven by the pie-1 promoter and 30UTR for maternal
expression (D’Agostino et al., 2006) and transformed by microparticle
bombardment (Praitis et al., 2001). GFP:MBK-2 is described in Pellettieri
et al. (2003) and rescues the mbk-2 null allele (pk1427). Mutations were
generated with QuickChange site-directed mutagenesis kit (Stratagene) and
confirmed by sequencing.Cell 139, 560–572, October 30, 2009 ª2009 Elsevier Inc. 569
RNAi
RNAi was performed using the feedingmethod (Timmons et al., 2001). Feeding
clones were grown in LB + ampicillin (100 mg/ml) at 37C and spread on NNGM
(nematode nutritional growthmedium) + Amp (100 mg/ml) + IPTG (80 mg/ml). L4
hermaphrodites were fed at 25C for 24–30 hr before examination.
Antibodies
Anti-EGG-4/5 and anti-MBK-2 sera were generated in rabbits against the
peptides CVSEKPKDEGRREDSGH and CKLVRNEKRFHRQADEEI, respec-
tively (Covance). Both antibodies blotted against whole worm extracts identi-
fied prominent bands migrating in the expected size range (Figure S6).
Immunofluorescence and Microscopy
Embryos and gonads were fixed on slides in 20C methanol (15 min)
and 20C acetone (10 min). Primary antibodies were rabbit anti-MBK-2
(1:5000, Covance), rabbit anti-EGG-4/5 (1:2500, Covance), guinea pig
anti-EGG-3 (1:10000, Covance), and rabbit anti-MEI-1-Ser92P (1:2000).
Secondary antibodies were Cy3 goat anti-rabbit (1:600, Jackson Immuno-
Research) and Alexa 568 goat anti-guinea pig (1:600, Molecular Probes).
Images were acquired with a Hamamatsu ORCA-ER digital camera attached
to a Zeiss Axioplan 2, processed with IPLab software (Scanalytics, Inc.) and
Photoshop CS.
Protein Preparation from Worm Extracts and Western Blotting
Staged hermaphrodites suspended in ice-cold lysis/homogenization buffer
(50mMHEPES [pH 7.4], 300mMKCl, 1mMMgCl2, 1mMEGTA, 10%glycerol,
0.5 mM DTT, 0.05% NP-40, phosSTOP phosphatase inhibitor cocktail tablet
[Roche], and complete Mini protease inhibitor tablet [Roche]) were frozen
dropwise in liquid nitrogen, grinded by mortar, and lysed by sonication.
Extracts centrifuged (4C, 14,000 rpm, 30 min) and filtered (0.22 mm filters;
Millipore) were precleared with protein A-agarose beads (Pierce) coupled to
rabbit IgG (Sigma). Precleared extracts were incubated with Protein A-agarose
beads coupled to anti-GFP or anti-MBK-2 antibodies,or EZview red M2
beads (Sigma—for FLAG-tagged fusions) at 4C overnight and washed three
times with ice-cold homogenization buffer. For phosphatase treatment, the
immunoprecipitates were incubated with Calf Intestinal Alkaline Phosphatase
(CIP) for 30 min at 37C. Precipitates and input were run on 4%–12% or 7%
SDS-PAGE (Invitrogen).
Preparation of Recombinant Proteins in E. coli
MBP fusions were grown in E. coli strain CAG456 and induced with
300 uM isopropyl-b-D-1-thiogalactopyranoside (IPTG) overnight at 15C.
Bacterial pellets were washed and resuspended in ice-cold column buffer
(20 mM Tris-HCl, 500 mM NaCl, 1 mM EDTA, 1 mM DTT, 10% glycerol),
passed once through a French Press, and centrifuged (SW41 rotor at 36,000
RPM, or equivalent, for 30 min). MBP fusions were purified from cleared
lysates by affinity chromatography (amylose resin, New England Biolabs)
and eluted with column buffer plus 10 mM maltose. Eluates were stored
at 80C.
FLAG and GST fusions were created as amino-terminal fusions using
pKC-5.02 and pDEST-15, respectively, and expressed in BL21(DE3) gold
(Invitrogen). Glutathione-Sepharose 4B beads (Amersham Pharmacia) were
incubated with GST-fusion extracts at 4C for 2 hr in PBST (phosphate-
buffered saline with 1% Triton X-100). EZview red M2 beads (Sigma) were
incubated with FLAG-fusion extracts in binding buffer (20 mM HEPES
[pH 7.6], 200 mM NaCl, 1 mM EDTA, 6% glycerol, 0.5 mM DTT, 0.1% NP-40
and complete mini protease inhibitor tablet [Roche]) at 4C for 2 hr and
washed. Bound proteins were eluted by boiling in 23 LDS sample buffer (Invi-
trogen) and subjected to 4%–12% SDS-PAGE (Invitrogen) for western blot
analysis.
The MBK-2 substrate MEI-1(51–150) was cloned into pGEX-6p-1 (amino-
terminal GST fusion), grown in BL21(DE3) gold (Invitrogen) induced with
500 uM IPTG at 37C for 2 hr. Bacteria pellets were resuspended in ice-cold
Lysis Buffer (phosphate-buffered saline, 10 mM EGTA, 10 mM EDTA, 0.25 M
NaCl, 0.2% Tween-20, 10 mM DTT, and complete mini protease inhibitor
tablet [Roche]) and sonicated. The crude extracts were centrifuged (SW41
rotor at 36,000 RPM, or equivalent, for 30 min) and incubated with Gluta-570 Cell 139, 560–572, October 30, 2009 ª2009 Elsevier Inc.thione-Sepharose 4B beads (Amersham Pharmacia) at 4C for 2 hr in Lysis
Buffer. Washed beads were incubated with Prescission Protease in Cleavage
Buffer (50 mM HEPES [pH 7.6], 150 mM NaCl, 1M EDTA, 0.01% Tween-20,
and 1 mM DTT) at 4C overnight. Recombinant MEI-1(51–150) was eluted in
Cleavage Buffer and stored at 80C.
Preparation of Recombinant Proteins in HEK293 Cells
HEK293 cells were maintained in Dulbecco’s modified Eagle’s medium
supplemented with 10% fetal bovine serum and 100 units/ml penicillin
and streptomycin. Cells were transfected using FuGENE 6 (Roche) according
to the manufacturer’s instructions. Cells were rinsed with ice-cold PBS
and lysed in lysis buffer (20 mM HEPES [pH 7.4], 0.2 M NaCl, 0.5% Triton
X-100, 5% glycerol, 1 mM EDTA, 1 mM EGTA, phosSTOP phophatase
inhibitor cocktail tablet [Roche], 1 mM dithiothreitol, and complete Mini
protease inhibitor cocktail tablet [Roche]). EZview red M2 beads (Sigma)
were incubated with cell extracts at 4C for 2 hr and washed five times
with ice-cold lysis buffer. The FLAG-tagged precipitates were subject
to 4%–12% SDS-PAGE and western blot analysis or kinase assays (see
below).
Kinase Assays
hCdk-1 Kinase Assays
hCdk-1 (20 units, New England Biolabs) was incubated with MBP fusions or
FLAG:fusions (on EZview red M2 beads) in 13 protein kinase buffer (New
England Biolabs) (50 mM Tris-HCl [pH 7.5], 10 mM MgCl2, 2 mM DTT, 1 mM
EGTA, 0.01% Brij 35) with cold or cold + 300 mCi/mmol g-32P-ATP (Amersham
Pharmacia) for 30 min. Reactions were stopped with 23 LDS sample
buffer (Invitrogen). Samples were boiled for 5 min and subject to 4%–12%
SDS-PAGE (Invitrogen—to measure 32P incorporation) or 7% SDS-PAGE (to
observe mobility shift).
MBK-2 Kinase Assays
Partially purified MBP:MBK-2 (0.1 mM) or immunoprecipitated GFP:MBK-2
(on protein A beads) or FLAG:MBK-2 (on EZview red M2 beads) were
incubated with MEI-1(51–150) in kinase buffer (50 mM Tris-HCl [pH 7.5],
10 mM MgCl2, 0.1 mM EGTA, 0.1% beta-mercaptoethanol [BME]) with
200 mM ATP and 300 mCi/mmol g-32P-ATP (Amersham Pharmacia) at 30C.
Reactions were stopped with 23 LDS sample buffer (Invitrogen). Samples
were boiled for 5 min and subject to 4%–12% SDS-PAGE (Invitrogen).
MEI-1(51–150) was visualized with SimplyBlue SafeStain (Invitrogen). 32P
incorporation was detected in the same gel by phosphorimager (Amersham
Pharmacia). Relative kinase activity was calculated by measuring 32P incorpo-
ration with ImageQuant 5.2 (Molecular Dynamics), normalizing for the
amount of MBK-2 (using anti:MBK-2 antibody for MBK-2 from mammalian
cells and worms), and expressing all values as ratios compared to wild-type
activity.
To analyze MBK-2 activity after phosphorylation by hCdk-1, MBP:
MBK-2 (0.1 mM) or immunoprecipitated FLAG:MBK-2 (on EZview red M2
beads) were treated with or without 20 units of hCdk-1 (New England Biolabs)
in 13 protein kinase buffer with 100 mM cold ATP at 30C for 30 min.
MBP:MBK-2 was repurified on maltose beads before performing the MBK-2
kinase assay. Maltose or EZview red M2 beads were washed twice with
13 kinase buffer and incubated with MEI-1(51–150) and 200 mM ATP and
300 mCi/mmol g-32P-ATP (Perkin Elmer) at 30C for 30 min. Samples were
boiled and run on 4%–12% SDS-PAGE. hCdk-1 does not phosphorylate
MEI-1 (Figure 2).
MBP:MBK-2 (0.1 mM), with or without FLAG:EGG-4 (0.2 mM) and with 7
concentrations of MEI-1(51–150) (0.1, 0.3, 0.7, 2, 3, 4, 5 mM), was used for
Figure 6C. The Michaelis-Menten kinetic curve was generated with Prizm 4
(GraphPad).
SUPPLEMENTAL DATA
Supplemental Data include eight figures and two tables and can be
found with this article online at http://www.cell.com/supplemental/S0092-
8674(09)01187-8.
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